AIPM announces that Nikita Ivanov has been elected the Vice Chairman of the AIPM Board of Directors

February 29, 2024, Moscow. - The Association of International Pharmaceutical Manufacturers (AIPM) announces the election of Nikita Ivanov, General Manager Pfizer Russia and Belarus, to the position of Vice Chairman of the AIPM Board of Directors. This decision was made at the Board meeting on February 28, 2024.

Nikita Ivanov has more than 18 years of pharmaceutical industry experience, holding various roles within Pfizer, progressing from a medical representative to the General Manager Pfizer Russia and Belarus. He has international experience across more than 15 markets. His areas of expertise include management of Business Unit operations (Sales and Marketing), business development, strategy and operations excellence, corporate affairs, market access and communications functions. He was first elected to the AIPM Board of Directors in June 2022.

Nikita Ivanov is a graduate of Pirogov Russian State Medical University with a degree in medical biochemistry and holds an EMBA diploma from the Antwerp Management School (Belgium).

«I am grateful to the Association and my colleagues for their trust. The interests of patients continue to be the primary focus for those who work in the pharmaceutical industry. I am excited about my new responsible role in the Association and the opportunity to be involved in implementing important initiatives aimed at developing cooperation, dialogue, effective partnership, protecting innovations and jointly finding solutions for the benefit of patients», said Nikita Ivanov.

The Association of International Pharmaceutical Manufacturers has always been a leading think-tank for the industry, working towards finding efficient approaches that foster development and innovative transformation in the sector, being in front of implementing advanced standards and regulatory practices, ensuring the quality of medicines, expanding their availability to a wide range of patients through maintaining transparent competition and contributing to multilateral professional dialogue among all stakeholders. The Association's most important values it stays committed since its foundation are intellectual property rights protection as the basis for future innovations and adherence to high ethical standards of doing business.

«The formation of the new AIPM Board of Directors is finalized with the election of Nikita Ivanov as the Vice-Chairman. In its 30th anniversary year, the Association is undergoing a transformation while still maintaining its key priorities — being a reliable partner for the healthcare system, maintaining open dialogue with the regulators, constantly working for the benefit of patients, and developing new tools that ensure access to treatment and medical knowledge, as well as enhancing the resilience of the healthcare system. The AIPM will continue its work in these directions and, I hope, will steadily achieve significant positive results», said Katerina Pogodina, Chair of the AIPM Board of Directors and Managing Director of Janssen, a pharmaceutical division of Johnson & Johnson, Russia and CIS.

Nikita Ivanov will take up his position as Vice Chairman of the Board of Directors from February 29, 2024. According to the AIPM Statutes the Vice Chair is elected for a term of two years with the option for one re-election.

Reference:

The Association of International Pharmaceutical Manufacturers (AIPM) was established in 1994 and represents in the Russian Federation the leading international pharmaceutical companies - producers and developers of modern effective, safe and high-quality medicines. Today, AIPM unites 58 international companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.

For additional information, please contact:

Elena Yankovskaya, PR & Communications Director, AIPM
+7 (495) 933 70 40, Elena.Yankovskaya@aipm.org